ArticleBMC cancer2023

CDC6, a key replication licensing factor, is overexpressed and confers poor prognosis in diffuse large B-cell lymphoma.

Mingfang Shen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.